Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-110530
Filing Date
2025-08-20
Accepted
2025-08-20 19:53:57
Documents
1
Period of Report
2025-08-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3716
  Complete submission text file 0000950170-25-110530.txt   5380
Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BLDG 34 BOSTON MA 02129
Business Address
Weis Holger (Reporting) CIK: 0001846984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 251238172